Curriculum Vitae of Mícheál O’Keeffe, Director of Policy and International at the Central Bank of Ireland and member of the EBA Board of Supervisors, detailing his professional experience in EU and Irish financial regulation, ECB roles, and academic background.
EBA public hearing on 2 September 2025 discussing draft guidelines for identifying ancillary services undertakings (ASU) under Regulation (EU) No 575/2013, covering criteria for banking-related and similar activities.
EBA public hearing on 3 September 2025 discussing draft regulatory products under CRD6 for third-country branches, including technical standards on booking arrangements, capital endowment guidelines, and supervisory cooperation frameworks.
EBA public hearing on 2 September 2025 discussing draft amendments to Regulatory Technical Standards (RTS) on bank own funds and eligible liabilities, covering proposed changes, consultation questions, and implementation timelines.
EBA public hearing on draft guidelines for credit conversion factor (CCF) estimation under CRR3, covering IRB-CCF scope, representativeness, realised CCF, and simple approaches – part of prudential regulation consultation held September 2025.
EBA public hearing on proposed amendments to Guidelines on Definition of Default under CRR3, covering NPV threshold for forbearance, updates to default definition, and next steps in consultation process – held September 2025.
European Banking Authority (EBA) public meeting register for 16-31 August 2025 – records no disclosed meetings involving Chairperson Jose Manuel Campa during this period.
European Banking Authority (EBA) public meeting register for August 1–15, 2025, listing engagements of Executive Director François-Louis Michaud – discloses no meetings during this period.
EBA public meeting register for August 2025 listing engagements of Executive Director François-Louis Michaud – discloses no meetings held between 16-31 August, covering transparency in stakeholder interactions.
EBA submits technical advice to the European Commission on determining fees and payment modalities for validating pro forma models under EMIR, supporting a delegated act to regulate costs for financial and non-financial counterparties.